|
Page 5 of 7 PCB Reduction and Clinical Improvement by Detoxification: An Unexploited Approach? Human and Experimental Toxicology, Vol.9, 1991. Summary: A female worker from a capacitor factory, with a history of exposure to polychlorinated biphenyls (PCBs) and other lipophilic industrial chemicals, was admitted for treatment at the University Medical Centre of Ljubljana, Slovenia (then Yugoslavia). She presented with severe abdominal complaints, chloracne, liver abnormalities and a bluish-green nipple discharge of approximately 50 ml in quantity. High PCB levels were noted in adipose tissue (102 mg kg'), serum (512 ug/1'), skin lipids (66.3 mg kg'), and in the nipple discharge (712 ug 1'). After detoxification, PCB levels in adipose tissue were reduced to 37.4 mg kg' and in serum to 261 ug', respective reductions of 63 percent and 49 percent. Excretion of intact PCBs in serum, appreciable before treatment, was enhanced by up to five-fold during detoxification. The nipple discharge ceased early in the detoxification regimen. Xenobiotic Reduction and Clinical Improvements in Capacitor Workers: A Feasible Method Journal of Environmental Science and Health, Vol. A25, No.7,1990. Summary: Eleven capacitor workers, occupationally exposed to PCBs and other industrial chemicals, underwent detoxification. Thirteen co-workers served as controls. Mean PCB levels prior to detoxification were 28.0 mg/kg in adipose and 188.0 ug/L in serum. Following detoxification, PCBs were reduced in serum by 42 percent (p<0.05) and in adipose by 30 percent for patients without concurrent disease. Patients with concurrent disease had a 10 percent reduction in adipose levels, while serum levels remained unchanged. Both adipose and serum PCB levels increased in members of the control group. At a four-month follow up examination, these differences were maintained, though the mean adipose PCB values in all groups were higher than at post-treatment. All patients reported marked improvement in clinical symptoms post-treatment, with most of these improvements retained at follow-up. No such improvements were noted in controls.
|